RxDoctor Payments Data

Zachary Steinberg, MD

Adult Congenital Heart Disease · Seattle, WANPI 1609023936

Payments from drug & device makers

$144,531in general payments, 2019–2025

Across 206 payments — averaging $701.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$99K
  • W. L. Gore & Associates, Inc.$22K
  • Edwards Lifesciences$10K
  • Abbott$5K
  • B. Braun Interventional Systems Inc.$4K
  • Neptune Medical Inc.$3K
  • plus $3K from 4 others
$11,438in research payments, 2019–2025

Across 3 payments — averaging $3812.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$11K

What the payments were for

  • Consulting fees$4,7554%
  • Speaking & faculty fees$85,08874%
  • Travel & lodging$15,49114%
  • Food & beverage$6,4996%
  • Other$2,5002%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)153$98,660
W. L. Gore & Associates, Inc.7$21,605
Edwards Lifesciences14$9,843
Abbott12$4,685
B. Braun Interventional Systems Inc.9$3,692
Neptune Medical Inc.1$2,968
Onocor, LLC1$2,500
Boston Scientific3$337
Cardiva Medical, Inc.5$130
Biotronik Inc.1$112

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult congenital heart disease providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$68,474
Medicare patients
107
Services billed
353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate11$122
Furosemide15$68

Paid to pharmacies, not to this prescriber.

Other adult congenital heart disease in Seattle

Where these figures come from

Is this you, or does something look wrong? →